Search

Shopping cart

Saved articles

You have not yet added any article to your bookmarks!

Browse articles
Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

GDPR Compliance

We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

Treatment of Breast Cancer with Natural  Products

Treatment of Breast Cancer with Natural Products

Treatment of Breast Cancer with Natural Based Products is designed to provide a wide spectrum of information and knowledge on phytotherapeutics in breast cancer treatment. With a strong focus on the established research and technology on phytoconstituent-based nanocarriers, the book also covers their rapidly emerging aspects and discusses future research directions in the treatment of breast cancer. Users will find insights into breast cancer symptoms, epidemiology, risk factors, screening, treatment, and drugs delivery systems. Other sections cover Curcumin, Paclitaxel, Quercetin, Resveratrol, Sulforaphane, Epigallocatechin-3-Gallate, Allicin, Berberine, and Vinca Alkaloids in the treatment of breast cancer, along with future perspectives.This book presents a groundbreaking opportunity for both academia and industry to reshape contemporary medical and healthcare approaches. With a specific emphasis on various facets of phytoconstituents within the realm of oncology, this publication serves as a precious asset for researchers, as well as graduate and post-graduate students specializing in oncology, pharmaceutical sciences, biotechnology, and related biomedical fields.
- Outlines the anticancer mechanisms shown by phytoconstituents
- Provides scholarly insights into recent developments in phytotherapeutics
- Assesses the opportunities and challenges of biopolymer-based nanocarriers in cancer research
- Focuses on the diverse, cutting-edge techniques for the fabrication of nanocarriers for the drug delivery of anticancer bioactives

Comments